Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of pre-clinical platform for tumor cancer. The company engages in generating preclinical platform of human cancer tumor immune-deficient mice xenografts namely Biomerk Tumorgrafts.
This information is reserved for PitchBook Platform users. To explore Biomerk‘s full profile, request access.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.